NOV 15, 2016 09:00 AM PST

Antigen-specific, poly-functional CD4+ T cells are required for vaccine-mediated protection in tularemia

Speakers
  • Rocky Mountain Laboratories, NIAID, NIH
    Biography
      Dr. Lydia Roberts received her undergraduate degrees in Chemistry and Biochemistry from Kansas State University in 2008 followed by her PhD in Microbiology and Immunology in 2013 from the University of North Carolina- Chapel Hill. Dr. Roberts is currently a post-doctoral fellow in the laboratory of Dr. Catharine Bosio at Rocky Mountain Laboratories, NIAID, NIH.

    Abstract:
    DATE: November 15, 2016
    TIME: 9:00 AM PT, 12:00 PM ET


    The virulent intracellular pathogen Francisella tularensis subsp. tularensis (Ftt) causes an acute, lethal disease called tularemia. Surviving tularemia depends on the presence of an effective adaptive immune response. However, the nature of such a response has not been elucidated. Thus, we designed in vitro and in vivo models to characterize the protective immune responses with the goal of applying these features to novel vaccines. Utilizing unlicensed vaccine strains with varying efficacy, we found that vaccinated mice lacking CD4+ T cells succumbed rapidly to Ftt challenge, surviving only 1 day longer than naïve animals. These data indicated that vaccine-mediated protection requires a pool of CD4+ T cells capable of immediately controlling Ftt replication. We found effective vaccination correlated with the presence of poly-functional CD4+ T cells producing IFN-γ, TNF-α, and IL-2 and these purified pulmonary and splenic CD4+ T cells controlled Ftt replication in vitro. To follow the antigen-specific response, we generated vaccine and Ftt strains expressing the well-characterized epitope gp61 from LCMV. Immune animals had persistent numbers of gp61-specific CD4+ T cells in their lymph nodes and spleens, whereas vaccinated, but non-immune animals did not. Therefore, we hypothesized the expansion of high avidity, antigen specific CD4+ T cells would convert a poorly efficacious vaccine to one that engenders protection. As predicted, inclusion of the gp61 epitope in both the vaccinating strain and virulent Ftt challenge strain converted a vaccine that failed evoke adequate T cell responses to one that was 100% protective. Together our work has revealed successful vaccines directed against an aggressive, highly pathogenic organism requires a large pool of high avidity, poly-functional CD4+ T cells. Moreover, the elucidation of Francisella epitopes that elicit high-avidity CD4+ T cell responses, specifically in humans, will be required for successful vaccine development

    Learning Objective 1: Learn about in vitro and in vivo immune response models to Francisella                                                 tularensis subsp. tularensis (Ftt) infection.

    Learning Objective 2: Learn how effective vaccination correlates with the presence of poly-                                                       functional CD4+ T cells.
     

    Show Resources
    You May Also Like
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    JUN 05, 2019 05:00 PM CEST
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    JUN 19, 2019 10:00 AM PDT
    JUN 19, 2019 10:00 AM PDT
    DATE: June 19, 2019TIME: 10:00am PDT, 1:00pm EDT As we develop new methods to create more biologically relevant models for research in understanding disease etiology and in...
    AUG 13, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 13, 2019 09:00 AM PDT
    DATE: August 13, 2019TIME: 9:00am PT, 12:00pm ET, 5:00pm BST Molecular complexes are major constituents of cells, hence unraveling their mechanisms is key to fuller comprehension of c...
    Loading Comments...
    Show Resources